CIK 0001178253
- Non-accelerated filer
- Smaller reporting company
SCYNEXIS INC
Sign in to watch- Ticker
- SCYX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 562181648
- Phone
- +1 201-884-5485
- Business address
- 1 EVERTRUST PLAZA, 13TH FLOOR, JERSEY CITY, NJ, 07302-6548
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-18 | Osborne, Jr. Charles F Chief Financial Officer | Grant or award · Stock Option (right to buy) | +833 | 833 | ||
| 2014-06-18 | Osborne, Jr. Charles F Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −833 | 0 | ||
| 2014-06-18 | Osborne, Jr. Charles F Chief Financial Officer | Grant or award · Stock Option (right to buy) | +57,420 | 57,420 | ||
| 2014-06-18 | Sable Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +46,636 | 46,636 | ||
| 2014-06-18 | Sable Carole Chief Medical Officer | Returned to the company · Stock Option (right to buy) | −46,636 | 0 | ||
| 2014-06-18 | Sable Carole Chief Medical Officer | Grant or award · Stock Option (right to buy) | +26,970 | 26,970 | ||
| 2014-06-18 | PRUETTE EILEEN General Counsel | Grant or award · Stock Option (right to buy) | +9,803 | 9,803 | ||
| 2014-06-18 | PRUETTE EILEEN General Counsel | Returned to the company · Stock Option (right to buy) | −9,803 | 0 | ||
| 2014-06-18 | PRUETTE EILEEN General Counsel | Grant or award · Stock Option (right to buy) | +25,230 | 25,230 | ||
| 2014-06-11 | Chaoui Mounia Director | Grant or award · Stock Option (right to buy) | +3,480 | 3,480 | ||
| 2014-06-11 | PENHOET EDWARD Director | Grant or award · Stock Option (right to buy) | +3,480 | 3,480 | ||
| 2014-06-11 | Nothias Jean-Yves Director | Grant or award · Stock Option (right to buy) | +3,480 | 3,480 | ||
| 2014-06-11 | Nothias Jean-Yves Director | Grant or award · Stock Option (right to buy) | +969 | 969 | ||
| 2014-06-11 | HANHAM ANN Director | Grant or award · Stock Option (right to buy) | +3,480 | 3,480 | ||
| 2014-06-11 | HANHAM ANN Director | Grant or award · Stock Option (right to buy) | +1,204 | 1,204 | ||
| 2014-06-11 | KIRBY PAMELA J Director | Grant or award · Stock Option (right to buy) | +5,220 | 5,220 | ||
| 2014-06-11 | KIRBY PAMELA J Director | Grant or award · Stock Option (right to buy) | +1,321 | 1,321 | ||
| 2014-06-11 | Arthaud Laurent Director | Grant or award · Stock Option (right to buy) | +3,480 | 3,480 | ||
| 2014-06-11 | Langlois Patrick Director | Grant or award · Stock Option (right to buy) | +3,480 | 3,480 | ||
| 2014-05-07 | F.C.P.R. Genavent 10% owner | Option exercise | +5,251 | $0.20 | $1K | 5,251 |
Page 20 of 26 · 507 trades